Penobscot Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$352K Hold
670
0.03% 249
2025
Q1
$425K Hold
670
0.04% 222
2024
Q4
$477K Hold
670
0.04% 209
2024
Q3
$704K Hold
670
0.06% 183
2024
Q2
$704K Hold
670
0.07% 179
2024
Q1
$645K Sell
670
-4
-0.6% -$3.85K 0.07% 185
2023
Q4
$592K Hold
674
0.07% 187
2023
Q3
$555K Hold
674
0.08% 174
2023
Q2
$484K Hold
674
0.08% 156
2023
Q1
$554K Sell
674
-375
-36% -$308K 0.1% 148
2022
Q4
$757K Hold
1,049
0.13% 129
2022
Q3
$723K Hold
1,049
0.13% 130
2022
Q2
$620K Hold
1,049
0.11% 145
2022
Q1
$733K Hold
1,049
0.11% 147
2021
Q4
$662K Buy
1,049
+124
+13% +$78.3K 0.09% 153
2021
Q3
$560K Hold
925
0.08% 157
2021
Q2
$517K Buy
925
+250
+37% +$140K 0.08% 158
2021
Q1
$319K Hold
675
0.05% 192
2020
Q4
$326K Hold
675
0.05% 180
2020
Q3
$378K Sell
675
-125
-16% -$70K 0.07% 155
2020
Q2
$499K Hold
800
0.1% 138
2020
Q1
$391K Hold
800
0.09% 141
2019
Q4
$300K Hold
800
0.06% 171
2019
Q3
$222K Hold
800
0.04% 188
2019
Q2
$250K Hold
800
0.05% 179
2019
Q1
$328K Hold
800
0.07% 160
2018
Q4
$299K Buy
800
+100
+14% +$37.4K 0.07% 156
2018
Q3
$283K Hold
700
0.06% 176
2018
Q2
$241K Hold
700
0.06% 187
2018
Q1
$241K Hold
700
0.06% 188
2017
Q4
$263K Hold
700
0.07% 169
2017
Q3
$313K Hold
700
0.09% 153
2017
Q2
$344K Hold
700
0.11% 146
2017
Q1
$271K Hold
700
0.09% 155
2016
Q4
$257K Hold
700
0.09% 157
2016
Q3
$281K Hold
700
0.1% 153
2016
Q2
$244K Hold
700
0.09% 162
2016
Q1
$252K Hold
700
0.09% 161
2015
Q4
$380K Hold
700
0.12% 143
2015
Q3
$326K Hold
700
0.11% 150
2015
Q2
$357K Hold
700
0.11% 157
2015
Q1
$316K Hold
700
0.1% 157
2014
Q4
$287K Hold
700
0.09% 157
2014
Q3
$252K Buy
+700
New +$252K 0.08% 161